Aurora Cannabis FY27 Q1 net loss narrows to C$4.03 million; revenue falls 9% to C$67.6 million

• Aurora Cannabis posted fiscal Q1 2027 net revenue of CAD 67.6 million, down 9% year over year.
• Net loss from continuing operations narrowed to CAD 4 million; adjusted EBITDA (non-GAAP) fell to CAD 3.4 million from CAD 10.8 million.
• Adjusted gross margin before fair value adjustments (non-GAAP) slipped 6 percentage points to 58%.
• International medical cannabis net revenue rose 17% to CAD 43.3 million, while Canadian medical cannabis net revenue fell 25% to CAD 20.7 million on lower reimbursement rates.
• Cash, cash equivalents and short-term investments totaled CAD 149.1 million with no debt; management expects Q2 revenue and adjusted EBITDA to rise sequentially.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aurora Cannabis Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202608050702PR_NEWS_USPR_____TO19470) on August 05, 2026, and is solely responsible for the information contained therein.